Published by Alexander Bueso on 28th April 2022
(Sharecast News) - Syncona committed further funding for rare-disease specialist OMass Therapeutics alongside a syndicate of investors which included a unit of French drug giant Sanofi.
URL: http://www.digitallook.com/dl/news/story/32637010/...